SLHG.H — Skylight Health Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -52.62% | ||
Return on Equity | -110.53% | ||
Operating Margin | -50.88% |
Financial Summary
Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 0.28 | 10.77 | 13.42 | 0.69 | 27.16 | 65.64 | 40 | 610.49% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools, including proprietary technology, data analytics and infrastructure. The Company has two segments related to its medical services and software and corporate businesses, which also align with the two countries in which it operates, namely, United States and Canada. It provides a range of healthcare services, including primary and urgent care, sub-specialists, allied health and wellness, and laboratory/diagnostic testing.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- December 27th, 2017
- Public Since
- March 6th, 2019
- No. of Employees
- 259
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
TSX Venture Exchange
- Shares in Issue
- 41,236,195

- Address
- 2275 Upper Middle Road East, Suite101, OAKVILLE, L6H 0C3
- Web
- https://skylighthealthgroup.com/
- Phone
- +1 4166421807
- Auditors
- Grant Thornton LLP
Upcoming Events for SLHG.H
Similar to SLHG.H
Field Trip Health & Wellness
TSX Venture Exchange
FAQ
As of Today at 23:21 UTC, shares in Skylight Health are trading at . This share price information is delayed by 15 minutes.
Shares in Skylight Health last closed at and the price had moved by -98.25% over the past 365 days. In terms of relative price strength the Skylight Health share price has underperformed the Toronto Stock Exchange 300 Composite Index by -98.42% over the past year.
The overall consensus recommendation for Skylight Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSkylight Health does not currently pay a dividend.
Skylight Health does not currently pay a dividend.
Skylight Health does not currently pay a dividend.
To buy shares in Skylight Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of , shares in Skylight Health had a market capitalisation of .
Here are the trading details for Skylight Health:
- Country of listing: Canada
- Exchange: NEX
- Ticker Symbol: SLHG.H
Based on an overall assessment of its quality, value and momentum Skylight Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Skylight Health. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -96.75%.
As of the last closing price of , shares in Skylight Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Skylight Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at .
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Skylight Health's directors